Neil E. Stahl - 08 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: EVP Research and Development
Signature: /s/**Neil Stahl
Issuer symbol: REGN
Transactions as of: 08 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Dec 2021, 16:35:01 UTC
Previous filing: 06 Dec 2021
Next filing: 14 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Award	$0	+2,926	+5.7%	$0.000000	53,883	08 Dec 2021	Direct	F1
holding	REGN	Common Stock						5,792	08 Dec 2021	By 401(k) Plan
holding	REGN	Common Stock						4,605	08 Dec 2021	by Spouse as Trustee

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Award	$0	+12,494		$0.000000	12,494	08 Dec 2021	Common Stock	12,494	$644.54	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2	The stock option award vests in four equal annual installments, commencing one year after the date of grant.